Glo

About

Medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are transforming weight and metabolic health management. However, the initial ninety days present challenges often underestimated. These include nausea, fatigue, food aversion, unanswered minor questions, unwelcome remarks from colleagues, and the uncertainty between monthly check-ins when concerns arise. Approximately a third of individuals discontinue these GLP-1 treatments within the first three months.